Detalhe da pesquisa
1.
Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practice.
Lancet Oncol
; 24(5): e197-e206, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142381
2.
Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials.
BMC Cancer
; 21(1): 1083, 2021 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34620124
3.
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium.
Lancet Oncol
; 21(2): e83-e96, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32007209
4.
Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaire core 30 scores in patients with ovarian cancer.
Gynecol Oncol
; 159(2): 515-521, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32972782
5.
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review.
Lancet Oncol
; 19(9): e459-e469, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30191850
6.
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials.
Clin Trials
; 15(6): 624-630, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30141714
7.
A joint model for repeated events of different types and multiple longitudinal outcomes with application to a follow-up study of patients after kidney transplant.
Biom J
; 57(2): 185-200, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25316383
8.
Validation of prediction models based on lasso regression with multiply imputed data.
BMC Med Res Methodol
; 14: 116, 2014 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-25323009
9.
Living on three time scales: the dynamics of plasma cell and antibody populations illustrated for hepatitis a virus.
PLoS Comput Biol
; 8(3): e1002418, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22396639
10.
Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types.
Eur J Cancer
; 188: 171-182, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37257278
11.
Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma - Interpretation guidance derived from two randomized EORTC trials.
Lung Cancer
; 167: 65-72, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35413526
12.
Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients.
Neuro Oncol
; 23(8): 1327-1336, 2021 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33598685
13.
Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancer.
Head Neck
; 42(11): 3141-3152, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32627261
14.
Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast Cancer.
JNCI Cancer Spectr
; 3(3): pkz037, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32328553
15.
Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanoma.
Eur J Cancer
; 104: 169-181, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30359910
16.
Corrigendum to "Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma - Interpretation guidance derived from two randomized EORTC trials" [Lung Cancer 167C (2022) 65-72].
Lung Cancer
; 171: 126, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35606221
17.
Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb-IVB mycosis fungoides/Sézary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT).
Eur J Cancer
; 156 Suppl 1: S22-S23, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34649647
18.
Prediction of COPD-specific health-related quality of life in primary care COPD patients: a prospective cohort study.
NPJ Prim Care Respir Med
; 24: 14060, 2014 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25164146